NASDAQ$AXON

Axon Enterprise Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Axon's Q3 2021 results were driven by strong performance across the board, with revenue growth of 39% and GAAP net income of $49 million, which supported Adjusted EBITDA of $51 million.

Axon reported strong Q3 2021 results, with record bookings of $488 million, up 54%. Revenue increased by 39% to $232 million, and GAAP net income was $49 million. The company also raised its 2022 revenue outlook to $1 billion.

  • Revenue grew 39% year-over-year to $232 million.
  • GAAP net income was $49 million, impacted by a $51 million tax benefit.
  • Annual recurring revenue grew 42% to $289 million.
  • Record Q3 bookings of $488 million were up 54%.

Headline financials

Total Revenue

$232M

Previous: $166M+39.4%
EPS (adj)

$1.17

Previous: $0.40+192.5%
Annual Recurring Revenue

$289M

Previous: $204M+41.6%
Capital Expenditures

-$36.5M

Previous: -$66M+44.7%
Free Cash Flow

$12M

Previous: -$66.9M+118.0%
Net Income

$48.5M

Previous: -$873K+5658.3%
Operating Income

$2.89M

Previous: -$5.45M+153.0%
Gross Profit

$145M

Previous: $98.2M+47.2%
Cash & Equivalents

$282M

Previous: $176M+60.1%
Total Assets

$1.65B

Previous: $1.28B+28.6%
Stock-Based Comp

$35.1M

Previous: $26.1M+34.4%

Revenue & EPS history

Axon · Revenue · Quarterly

$232M

Q3 2021+39.4%vs Q3 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Axon · $121M total across 1 segment · Q3 2021

  • TASER
    $121M+43.9%

Forward guidance

Axon expects to achieve revenue at the high end of its previously communicated range of $840 million to $850 million for 2021. The company also expects stock-based compensation expense to be more than $300 million for the full year and anticipates at least $1.0 billion in revenue for 2022.

Tailwinds

  • Revenue at the high end of the previously communicated range of $840 million to $850 million.
  • Full year revenue of $850 million represents 25% growth over 2020.
  • TASER 7 demand remains exceptionally strong and backlog continues to grow.
  • Adjusted EBITDA to a range of $163 million to $168 million, from a range of $155 million to $160 million, previously.
  • Strengthening view of the business in 2022 includes at least $1.0 billion in revenue.

Headwinds

  • Approximately $30 million of previously anticipated Q4 2021 TASER segment revenue will shift into the first half of 2022 resulting from industry-wide chip shortages that impacted TASER 7 platform.
  • Q4 2020 benefitted from a $20 million TASER 7 order from an international customer.
  • Stock-based compensation expense to be more than $300 million for the full year.
  • Capital expenditures of approximately $65 million to $70 million in 2021 are unchanged.
  • Inherent difficulty of forecasting certain types of expenses such as stock-based compensation and income tax expenses, which affect net income but not Adjusted EBITDA.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+3.4%

Avg return

Earnings day

+6.6%

Avg return

5 days after

+6.7%

Avg return

30 days after

55%

35 / 64 earnings

Positive

+31.3%

Q3 2024

Best reaction

-17.1%

Q4 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.4%+3.1%+27.9%
Q4 2025+1.1%+29.3%-2.8%
Q3 2025+13.7%-17.2%-22.0%
Q1 2025+14.2%+20.4%+31.6%
Q4 2024+15.3%+5.9%+7.7%
Q3 2024+31.3%+29.5%+49.7%
Q2 2024+22.0%+27.6%+24.0%
Q1 2024-1.8%-4.7%-11.4%
Q4 2023+13.9%+15.7%+15.2%
Q3 2023+5.9%+0.5%+8.5%
Q2 2023+11.6%+17.6%+20.3%
Q1 2023-13.1%-9.2%-12.2%
Q4 2022+13.4%+13.3%+11.7%
Q3 2022+15.8%+23.2%+15.7%
Q2 2022+8.5%+11.4%+5.6%
Q1 2022-4.0%+11.8%+15.0%
Q4 2021+9.6%+16.1%+8.4%
Q3 2021+4.3%+6.8%-13.4%
Q2 2021+0.8%-3.8%-3.3%
Q1 2021-4.6%-6.6%-0.1%
Q4 2020+2.5%+2.9%-14.6%
Q3 2020+16.7%+13.3%+18.2%
Q2 2020-9.5%-14.5%-10.8%
Q1 2020+30.2%+26.2%+40.3%
Q4 2019-3.8%-2.9%-7.5%
Q3 2019+25.0%+22.5%+37.6%
Q2 2019-11.4%-10.3%-5.4%
Q1 2019-4.9%-1.0%+3.3%
Q4 2018-4.4%-6.2%-7.2%
Q3 2018-16.1%-13.6%-26.4%
Q2 2018-10.6%-8.1%+5.1%
Q1 2018+21.6%+27.4%+41.4%
Q4 2017+23.7%+37.6%+39.6%
Q3 2017-7.7%-8.9%+4.8%
Q2 2017-10.5%-13.1%-16.4%
Q1 2017+4.8%+3.8%-2.4%
Q4 2016-6.7%-12.5%-11.0%
Q3 2016+19.3%+22.3%+6.0%
Q2 2016+1.9%-0.1%-7.5%
Q1 2016+2.9%
Q4 2015+11.2%
Q3 2015-13.8%
Q2 2015-14.1%
Q1 2015+15.3%
Q4 2014-13.2%
Q3 2014+14.4%
Q2 2014+4.9%
Q1 2014-10.7%
Q4 2013+7.3%
Q3 2013+13.5%
Q2 2013-0.2%
Q1 2013+7.8%
Q4 2012-17.1%
Q3 2012-1.7%
Q2 2012-1.1%
Q1 2012+0.0%
Q4 2011-0.5%
Q3 2010-2.7%
Q3 2011-2.7%
Q2 2010-2.7%
Q2 2011-2.7%
Q1 2011+4.8%
Q4 2010-4.8%
Q1 2010+6.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro